Results from Figs. 1A and 1B demonstrated a significant reduction in CES1 mRNA expression across various human cancers, including bladder, cholangiocarcinoma, renal cell carcinoma, and endometrial cancer. This evidence concerns the gene CES1 and hereditary clear cell renal cell carcinoma.